Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 3/20 | 0.40 |
| ▸ | AR | P10275 | 9/20 | 0.39 |
| ▸ | PGR | P06401 | 2/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.34 |
| ▸ | MAT2A | P31153 | 1/20 | 0.34 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21116476 | 0.94 | KIF11 (0.48) | CYP11B1CYP11B2KIF11ARPGR | |
| SCHEMBL21116346 | 0.93 | KIF11 (0.45) | CYP11B1CYP11B2KIF11ARPGR | |
| SCHEMBL21116870 | 0.89 | CYP11B1 (0.42) | CYP11B1CYP11B2KIF11ARPGR | |
| SCHEMBL21116257 | 0.89 | CYP11B1 (0.41) | CYP11B1CYP11B2KIF11ARPGR | |
| SCHEMBL21116272 | 0.88 | AR (0.43) | CYP11B1CYP11B2ARPGRALOX5AP | |
| SCHEMBL21116849 | 0.87 | KIF11 (0.41) | CYP11B1CYP11B2KIF11ARPGR | |
| SCHEMBL21116548 | 0.86 | KIF11 (0.39) | KIF11ARPGRMAT2A | |
| SCHEMBL20114669 | 0.86 | PSEN1 (0.36) | CYP11B1CYP11B2KIF11ARALOX5AP | |
| SCHEMBL21116263 | 0.85 | KIF11 (0.42) | CYP11B1CYP11B2KIF11ARPGR | |
| SCHEMBL23798833 | 0.84 | KIF11 (0.45) | CYP11B1CYP11B2KIF11ARPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| EP-3478656-B1 | DICARBAZOLE DIPHENYL DERIVATIVES FOR USE IN OPTOPELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-09-08 | — | — | EP | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | CYP11B1 1343/4885CYP11B2 1090/4885KIF11 3544/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | CYP11B1 1257/4885CYP11B2 1121/4885KIF11 3520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.